TARO PHARMACEUTICAL INDUSTRIES LTD
CIK 0000906338
Revenue (TTM)
$572.95M
+2.1% YoY
FY Mar 2023
Net Income (TTM)
$25.45M
−56.3% YoY
FY Mar 2023
EPS Diluted (TTM)
$0.68
−56.1% YoY
FY Mar 2023
Gross Margin
46.8%
FY Mar 2023
Operating Margin
3.1%
FY Mar 2023
Net Margin
4.4%
FY Mar 2023
Free Cash Flow (TTM)
$14.17M
FY Mar 2023
Cash
$154.5M
FY Mar 2023
Total Debt
$5.89M
FY Mar 2023
Shares Outstanding
37.58M sh
FY Mar 2023